In the past decade, a growing body of literature has reported promising results for prostate-
specific membrane antigen (PSMA)-targeted radionuclide imaging and therapy in prostate …

Simple Summary Positron emission tomography/computed tomography (PET/CT) has an
increasingly relevant role in the management of oncological patients. It consists of the …

Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third most
frequent cause of cancer-related death. A growing number of local and systemic therapies …

Blocking the interaction of the immune checkpoint molecule programmed cell death protein-
1 and its ligand, PD-L1, using specific antibodies has been a major breakthrough for …

Prostate‐specific membrane antigen (PSMA) is a validated target for molecular diagnostics
and targeted radionuclide therapy. Our purpose was to evaluate PSMA expression in …

Purpose Prostate-specific membrane antigen (PSMA) is not only highly expressed on the
surface prostate cancer cells but is also elevated during angiogenesis in other cancer cell …

Prostate-specific membrane antigen (PSMA) is expressed in a variety of cancer cells, while
the fibroblast activation protein (FAP) is expressed in the microenvironment of tumors …

Radiolabeled biomolecules targeted at tumor-specific enzymes, receptors, and transporters
in cancer cells represent an intensively investigated and promising class of molecular tools …

Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver,
but early diagnosis and effective treatment are still difficult. With the development of …

Among the nanomaterials, rare sesquioxides (lanthanide oxides such as Lu 2 O 3) are of
interest due to their adequate thermal conductivity, excellent chemical stability, and high …